These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25948305)

  • 1. [Altered expression of transporter and analgesic of morphine in neuropathic pain mice].
    Ochiai W; Sugiyama K
    Yakugaku Zasshi; 2015; 135(5):703-8. PubMed ID: 25948305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain.
    Ochiai W; Kaneta M; Nagae M; Yuzuhara A; Li X; Suzuki H; Hanagata M; Kitaoka S; Suto W; Kusunoki Y; Kon R; Miyashita K; Masukawa D; Ikarashi N; Narita M; Suzuki T; Sugiyama K
    Eur J Pharm Sci; 2016 Sep; 92():298-304. PubMed ID: 27102159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for Increased Expression of UGT2B in the Liver of Mice with Neuropathic Pain.
    Kaneta M; Ochiai W; Nagae M; Suto W; Hanagata M; Suzuki H; Kitaoka S; Hatogai J; Ikarashi N; Sugiyama K
    Biol Pharm Bull; 2016; 39(11):1809-1814. PubMed ID: 27803452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
    Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.
    Kobori T; Fujiwara S; Miyagi K; Harada S; Nakamoto K; Nakagawa T; Takahashi H; Narita M; Tokuyama S
    Drug Metab Pharmacokinet; 2014; 29(6):482-9. PubMed ID: 25048710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T; De Vry J; Tzschentke TM
    Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Cancer Pain and Medical Narcotics].
    Suzuki T
    Yakugaku Zasshi; 2015; 135(12):1325-34. PubMed ID: 26632147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toluene and TCE decrease binding to mu-opioid receptors, but not to benzodiazepine and NMDA receptors in mouse brain.
    Páez-Martínez N; Ambrosio E; García-Lecumberri C; Rocha L; Montoya GL; Cruz SL
    Ann N Y Acad Sci; 2008 Oct; 1139():390-401. PubMed ID: 18991886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapy for neuropathic pain.
    Mizoguchi H; Watanabe C; Yonezawa A; Sakurada S
    Int Rev Neurobiol; 2009; 85():249-60. PubMed ID: 19607975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-glycoprotein by Anti-cancer Drugs].
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    Yakugaku Zasshi; 2015; 135(5):687-95. PubMed ID: 25948303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine metabolism. II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats.
    Del Villar E; Sanchez E; Tephly TR
    Drug Metab Dispos; 1974; 2(4):370-4. PubMed ID: 4153409
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA affects oral morphine analgesia depending on functional variation in intestinal P-glycoprotein induced by repeated etoposide treatment.
    Kobori T; Kobayashi M; Harada S; Nakamoto K; Fujita-Hamabe W; Tokuyama S
    Eur J Pharm Sci; 2012 Dec; 47(5):934-40. PubMed ID: 22982667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice.
    Kim W; Kim MJ; Go D; Min BI; Na HS; Kim SK
    Toxins (Basel); 2016 Jan; 8(2):33. PubMed ID: 26805884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
    Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
    J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy.
    Balayssac D; Cayre A; Ling B; Maublant J; Penault-Llorca F; Eschalier A; Coudoré F; Authier N
    Neurosci Lett; 2009 Nov; 465(1):108-12. PubMed ID: 19733628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.
    Pilat D; Piotrowska A; Rojewska E; Jurga A; Ślusarczyk J; Makuch W; Basta-Kaim A; Przewlocka B; Mika J
    Mol Cell Neurosci; 2016 Mar; 71():114-24. PubMed ID: 26763728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.